In this role, Dr Vaishnaw will be responsible for continued leadership of the company’s clinical activities; he will continue to report to John Maraganore, Alnylam’s CEO.
Dr Vaishnaw joined Alnylam in February 2006 as vice president of clinical research. Dr Vaishnaw has also served as a member of Alnylam’s management team. Prior to Alnylam, Akshay served as senior director, translational medicine at Biogen Idec.
Mr Maraganore said: “Over the past few years, Akshay has demonstrated tremendous leadership in his role at Alnylam and has been instrumental in the advancement of our pipeline. These are exciting times for the field of RNAi therapeutics, as important scientific and clinical advancements are being made at a very rapid pace.”